The European Commission has approved Truxima, a rituximab biosimilar, for all indications of reference rituximab in the European Union (EU). Truxima is a mAb that targets CD20, a protein found on the surface of most B cells. Overactive B cells can...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2lyO6O2
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: Available online 5 April 2017 Source: European Annals of Otorhinolaryngology, Head and Neck Diseases Author(s): C.A. Ri...
-
Be a Responsible Dog Owner . Among companion animals, dogs are unmatched in their devotion, loyalty and friendship to humankind. Anyone who ...
-
Related Articles Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease in the Canary Islands (CCECAN study...
-
Business Cover Letter Writing. The business professional can include a fairly broad group, so make sure you that cold cover letters have a j...
-
Explore research at Microsoft, a site featuring the impact of research along with publications, products, downloads, and research careers. ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου